nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials
|
Shin, Dong-Yeop |
|
|
143 |
C |
p. |
artikel |
2 |
Editorial Board
|
|
|
|
143 |
C |
p. |
artikel |
3 |
Identification of clonal relationship and prognostic significance in acute myeloid leukemia patients with concomitant increase in mast cells
|
Xu, Zhifang |
|
|
143 |
C |
p. |
artikel |
4 |
Impact of leukemia-associated macrophages on the progression and therapy response of chronic lymphocytic leukemia
|
Jestrabek, Hendrik |
|
|
143 |
C |
p. |
artikel |
5 |
Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation
|
Zulch, Emma |
|
|
143 |
C |
p. |
artikel |
6 |
Less is more: An analysis of venetoclax and hypomethylating agent post-induction treatment modifications in AML
|
Boisclair, Stephanie |
|
|
143 |
C |
p. |
artikel |
7 |
MD-1 downregulation is associated with reduced cell surface CD180 expression in CLL
|
Edwards, Kurtis |
|
|
143 |
C |
p. |
artikel |
8 |
Molecular characterization of V(D)J rearrangements in immature acute leukemias
|
Vianna, Danielle Tavares |
|
|
143 |
C |
p. |
artikel |
9 |
Multiple myeloma and infections in the era of novel treatment modalities
|
Akhmedov, Mobil |
|
|
143 |
C |
p. |
artikel |
10 |
Post-transplant cyclophosphamide: A double-edged sword?
|
Busca, Alessandro |
|
|
143 |
C |
p. |
artikel |
11 |
Unmutated IGHV at diagnosis in patients with early stage CLL independently predicts for shorter follow-up time to first treatment (TTFT)
|
Galieni, Piero |
|
|
143 |
C |
p. |
artikel |